Transactions — FEATURED NEWS Home — Back Bay Life Science Advisors

DNB Markets, Back Bay Life Science Advisors and KD Pharma

Transaction UpdatesDNB//Back BayOctober 10, 2024M&A, Transactions, DNB//Back Bay

Palette Life Sciences to be Acquired by Teleflex

Back Bay Life Science AdvisorsJuly 26, 2023Transactions, Investment Banking

Back Bay Served as an Advisor to AMG in Transaction with Forbion

Back Bay News, Back Bay Transaction NewsInvestment Banking TeamJune 27, 2023Transactions

The Transactional Landscape Of ADCs: A Payday for Payloads

BlogBack Bay Life Science AdvisorsMarch 2, 2023Capital, Biotech, M&A, Oncology, Transactions, Deal Landscape, Small Molecule Therapeutics

Versantis to be acquired by GENFIT

Press Release, Client NewsBack Bay Life Science AdvisorsSeptember 19, 2022Transactions, Diligence, Biotech, M&A

Back Bay Advised Caladrius Biosciences on Merger with Cend Therapeutics

Back Bay Life Science Advisors’ investment banking and strategy teams announced their role in the deal between Caladrius Biosciences, now called Lisata Therapeutics, and Cend Therapeutics